Employment Type : Full-Time
Job Description The Associate Director, Market Access, Biosimilars will report to the Director of Strategic Pricing and Contracting and be responsible for the development of the US launch pricing and contracting strategy for the US Biosimilars Business Unit, with an initial focus in Ophthalmology. Specifically, s/he will be responsible for the strategic approach to biosimilar pricing and delivering recommended contracting strategy by customer segment. This includes but is not limited to identifying potential innovative contracting frameworks (e.g., outcomes/value-based contracting); developing the post-launch contracting strategy plan; and building pricing proposals, business cases (in collaboration with Finance), and internal pricing communications. The individual will work closely with the US Contracting Operations team to ensure contracting and pricing strategy is aligned with field implementation and pull-through. Working with the Health Policy team to apply anticipated policy changes related to biosimilars into future contracting scenario planning will be critical. This individual will be required to work cross-functionally to achieve the business objectives described above and ensure organizational alignment and approvals. The individual will partner with the Payer Channel Marketing and the Payer Insights teams to align payer value proposition, collect key customer insights, and analyze market in terms of coverage and reimbursement, payer policies, formulary listings, and barriers to patient access. Work with cross-functional teams (Contracting Operations, Field Marketing, etc.) will be required to support training and educating account managers on contracting strategies. Collaboration with the Health Policy and Government Affairs team to integrate anticipated policy changes into future approaches towards contracting with government and private payers is important. The Associate Director, Market Access, Biosimilars will report to the Director of Strategic Pricing and Contracting and be responsible for the development of the US launch pricing and contracting strategy for the US Biosimilars Business Unit, with an initial focus in Ophthalmology.
Qualifications
Additional Information